Arrowhead Research reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 1.06M 0.78M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Arrowhead Research ARWR:US $ 0 0
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
IONIS PHARMACEUT IONS:US $ 1248.4M 0.47M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 641M 5M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 23784M 589M
Opko Health OPK:US $ 217.74M 1.39M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.16M 0.23M